Reboxetine is an antidepressant that functions as a NorAdrenaline Reuptake Inhibitor (NARI).

  1.   Reboxetine  role in antidepressant therapy                                               
  2.   Reboxetine  clinical efficacy in major depression
  3.   Reboxetine  efficacy and tolerability
  4.   Reboxetine  tolerability and safety for major depression
  5.   Reboxetine  effect on social behavior
  6.   Reboxetine  effect on panic disorder
  7.   Reboxetine  does it offer advantages over SSRIs?
  8.   Reboxetine  improves symptoms of anxiety and cognitive disturbance
  9.   Reboxetine  with severe major depressive disorder
 10.  Reboxetine  place in antidepressant therapy
 11.  Reboxetine  prevents relapse in  major depression
 12.  Reboxetine  effects of antidepressant therapy
 13.  Reboxetine  is more effective than fluoxetine in patients with severe depression
 14.  Reboxetine  versus fluoxetine, impact on social functioning
 15.  Reboxetine  is more effective than fluoxetine in improving social functioning
 16.  Reboxetine  and depression in the elderly
 17.  Reboxetine  efficacy compared with imipramine
 18.  Noradrenaline reuptake inhibition
 19.  Antidepressants  noradrenergic versus serotonergic
 20.  Reboxetine  is an option for the treatment of bulimia nervosa
 21.  Reboxetine  hemodynamic effects in healthy males
 22.  Reboxetine  Inhibiting noradrenaline and serotonin reuptake 
 23.  Reboxetine  clinical pharmacologic profile
 24.  Reboxetine  stimulant effects in patients with narcolepsy
 25.  Reboxetine  selective noradrenaline reuptake inhibitor (NARI)

        Reboxetine  manufacturer's product insert      www.AlzheimersTreatments.com